HEMATOLOGY

Latest News

ADCs Change the Game for Cancer Treatment
ADCs Change the Game for Cancer Treatment

May 29th 2024

In part 2 of our 3-part series, antibody-drug conjugates like enfortumab vedotin and tisotumab vedotin offer novel options for difficult-to-treat tumors.

Vibecotamab Shows Safety/Activity in Low-Blast, High-Risk Myeloid Diseases
Vibecotamab Shows Safety/Activity in Low-Blast, High-Risk Myeloid Diseases

May 28th 2024

Antibody-Drug Conjugates Continue to Transform the Oncology Landscape
Antibody-Drug Conjugates Continue to Transform the Oncology Landscape

May 28th 2024

More GVHD Complications Observed Among Patients With Obesity
More GVHD Complications Observed Among Patients With Obesity

May 25th 2024

Why Physicians Recommend Tagraxofusp in BPDCN
Why Physicians Recommend Tagraxofusp in BPDCN

May 20th 2024

Video Series
Video Interviews

More News